These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1492497)

  • 21. Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease.
    Liberski PP; Budka H; Sluga E; Barcikowska M; Kwiecinski H
    Eur J Epidemiol; 1991 Sep; 7(5):551-5. PubMed ID: 1761114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie.
    Sklaviadis T; Manuelidis L; Manuelidis EE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6146-50. PubMed ID: 3090551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants.
    Manuelidis L; Valley S; Manuelidis EE
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4263-7. PubMed ID: 2408277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 26. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen.
    Tateishi J; Tashima T; Kitamoto T
    Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Creutzfeldt-Jakob disease: light microscopic, immunohistochemical and ultrastructural studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in NIH Swiss mice.
    Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC
    Neuropatol Pol; 1991; 29(1-2):1-17. PubMed ID: 1813811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scrapie-associated precursor proteins: antigenic relationship between species and immunocytochemical localization in normal, scrapie, and Creutzfeldt-Jakob disease brains.
    Safar J; Ceroni M; Piccardo P; Gajdusek DC; Gibbs CJ
    Neurology; 1990 Mar; 40(3 Pt 1):513-7. PubMed ID: 1969126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies.
    Manuelidis L
    Ann N Y Acad Sci; 1994 Jun; 724():259-81. PubMed ID: 8030947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.
    Brown P; Wolff A; Gajdusek DC
    Neurology; 1990 Jun; 40(6):887-90. PubMed ID: 1693181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Manuelidis EE
    EMBO J; 1987 Feb; 6(2):341-7. PubMed ID: 3556164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Creutzfeld-Jakob disease: recent advances; biology of unconventional viruses (author's transl)].
    Cathala F; Moreau-Dubois MC; Brown P
    Pathol Biol (Paris); 1980 Oct; 28(8):545-53. PubMed ID: 6776473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of scrapie agents: how far have we come?
    Bolton DC; Bendheim PE
    Curr Top Microbiol Immunol; 1991; 172():39-55. PubMed ID: 1687384
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane filtration and the Creutzfeldt-Jakob agent.
    Taylor DM
    Lancet; 1985 Dec 21-28; 2(8469-70):1430-1. PubMed ID: 2867425
    [No Abstract]   [Full Text] [Related]  

  • 37. Bovine spongiform encephalopathy in cattle mimics ultrastructurally experimental scrapie and Creutzfeldt-Jakob disease in rodents.
    Liberski PP; Yanagihara R; Wells GA; Gajdusek DC
    Neuropatol Pol; 1993; 31(1-2):1-16. PubMed ID: 8208436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material.
    Oleszak EL; Manuelidis L; Manuelidis EE
    J Neuropathol Exp Neurol; 1986 Sep; 45(5):489-502. PubMed ID: 3528396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scrapie and Creutzfeldt-Jakob disease prions.
    Prusiner SB; Barry RA; McKinley MP; Bellinger CG; Meyer RK; DeArmond SJ; Kingsbury DT
    Microbiol Sci; 1985; 2(2):33-9. PubMed ID: 3940147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of the scrapie agent by density gradient centrifugation.
    Marsh RF; Dees C; Castle BE; Wade WF; German TL
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():415-21. PubMed ID: 6420511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.